Recent breakthroughs in medicine?

Several medical advances have recently moved from promising research into real-world treatment. They don’t cure every patient, and access can still be difficult, but they are changing what doctors can offer.

• CRISPR-based treatment: Casgevy became the first approved therapy using CRISPR gene editing. It offers some people with sickle cell disease or transfusion-dependent beta thalassemia a treatment aimed at the underlying cause, though the process is intensive and requires specialist care.
• New Alzheimer’s drugs: Lecanemab and donanemab can slow cognitive decline for some people in the early stages of Alzheimer’s. Their effects are modest, and treatment involves monitoring for potentially serious brain swelling or bleeding.
• Obesity medicines with broader benefits: GLP-1 medicines such as semaglutide have transformed obesity care. Research has also shown heart-related benefits for certain patients, extending interest in these drugs beyond weight loss.
• Malaria vaccines: RTS,S and R21 vaccines are being introduced in countries where malaria is common. They are not complete protection, but they add an important tool for reducing severe illness in children.

What counts as a breakthrough depends on the condition: a treatment may be a major advance while still having limits, side effects, or a high cost. The most meaningful progress is often a new option for patients who previously had few.